109133001: Product containing daclizumab (medicinal product)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing daclizumab

\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing daclizumab

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

173668019 Daclizumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
608568012 Daclizumab (substance) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
1185618012 Daclizumab (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT core module
3524336013 Product containing daclizumab (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3524337016 Product containing daclizumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3665808018 Daclizumab product en Synonym Inactive Entire term case insensitive SNOMED CT core module
3714244013 Daclizumab-containing product en Synonym Active Entire term case insensitive SNOMED CT core module
107653701000001116 Daclizumab en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing daclizumab	Is a	Product containing monoclonal antibody	true	Inferred relationship	Existential restriction modifier
Product containing daclizumab	Has active ingredient	Daclizumab	true	Inferred relationship	Existential restriction modifier	1
Product containing daclizumab	Has active ingredient	Monoclonal antibody	false	Inferred relationship	Existential restriction modifier
Product containing daclizumab	Is a	Product containing murine-human monoclonal immunoglobulin G antibody	false	Inferred relationship	Existential restriction modifier
Product containing daclizumab	Is a	Product containing immunomodulator	true	Inferred relationship	Existential restriction modifier
Product containing daclizumab	Is a	Virtual therapeutic moiety	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Daclizumab 25mg/5mL infusion concentrate	Is a	False	Product containing daclizumab	Inferred relationship	Existential restriction modifier
Daclizumab 25mg/5 mL solution	Is a	False	Product containing daclizumab	Inferred relationship	Existential restriction modifier
Daclizumab 25mg/5mL infusion concentrate	Is a	False	Product containing daclizumab	Inferred relationship	Existential restriction modifier
Daclizumab 25mg/5mL conventional release solution for injection	Is a	False	Product containing daclizumab	Inferred relationship	Existential restriction modifier
Daclizumab	Is a	True	Product containing daclizumab	Inferred relationship	Existential restriction modifier
Product containing daclizumab in parenteral dose form (medicinal product form)	Is a	True	Product containing daclizumab	Inferred relationship	Existential restriction modifier
Daclizumab 150mg/1ml solution for injection pre-filled disposable devices	Is a	False	Product containing daclizumab	Inferred relationship	Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials	Is a	False	Product containing daclizumab	Inferred relationship	Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials	Is a	False	Product containing daclizumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets